0
0
Industry
Geography
Report Type
Themes
Price
Publication date
Published Date
  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Reata Pharmaceuticals Inc

    Reata Pharmaceuticals Inc (Reata) is a clinical-stage biopharmaceutical company. It develops innovative medicines for the treatment of serious and life-threatening diseases. The company's clinical candidates include bardoxolone methyl and omaveloxolone, which target Nrf2, a transcription factor, for restoring mitochondrial function, reducing oxidative stress, and resolving inflammation. Its products also include HSP90 modulators, RTA 901, RORγt inhibitors, and RTA 1701. Reata is evaluating bardoxolone methyl in connective tissue disease-associated pulmonary arterial hypertension (CTD-PAH), alport syndrome and other kidney diseases; and omaveloxolone...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Oramed Pharmaceuticals Inc

    Oramed Pharmaceuticals Inc (Oramed) is a pre-clinical pharmaceutical company that carries out research and development of novel pharmaceutical solutions, comprising an oral insulin capsule used for the treatment of people with diabetes and orally ingestible capsules for delivery of other polypeptides. It developed a novel proprietary platform technology, protein oral delivery (POD) to transform injectable treatments into oral therapies. The technology allows for the oral delivery of drugs and is administered only by injection. Its pipeline products are intended for...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Kiniksa Pharmaceuticals Ltd

    Kiniksa Pharmaceuticals Ltd (Kiniksa) is a biopharmaceutical company that discovers, acquires, develops and commercializes medicines to treat autoinflammatory and autoimmune diseases. The company's pipeline product portfolio includes Rilonacept drug for the treatment of recurrent pericarditis; mavrilimumab, against giant cell arteritis, COVID-19 and hyper inflammation; vixarelimab, targeting prurigo nodularis and diseases characterized by chronic pruritus; KPL-404, a monoclonal antibody to treat T-cell dependent, B-Cell–mediated indications. It develops medicines in the therapeutic areas of cardiovascular, dermatology and autoimmune diseases. The company has...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Eloxx Pharmaceuticals Inc

    Eloxx Pharmaceuticals Inc (Eloxx), formerly Sevion Therapeutics Inc, is a clinical-stage biopharmaceutical company that develops novel RNA-modulating drug candidates for the treatment of rare and ultra-rare premature stop codon diseases. The company's lead product candidate, ELX-02, is in Phase II clinical trials for the treatment of cystic fibrosis. Its preclinical candidates include novel ERSG drug candidates for the treatment of autosomal dominant polycystic kidney disease (ADPKD) and Usher syndrome. The company has a subsidiary in Israel. Eloxx is headquartered in...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Idorsia Pharmaceutical Ltd

    Idorsia Pharmaceutical Ltd (Idorsia) is a biopharmaceutical company that discovers, develops, and commercializes small molecules to treat the central nervous system and cardiovascular and immunological disorders. It is investigating daridorexant against insomnia; aprocitentan for the treatment of resistant hypertension; clazosentan to treat cerebral vasospasm associated with aneurysmal subarachnoid hemorrhage; and L-lucerastat compound targeting fabry disease. The company is also evaluating drugs against suspected acute myocardial infarction, systemic lupus erythematosus, Binge eating disorder and rare lysosomal storage disorders. It works in...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Jazz Pharmaceuticals Plc

    Jazz Pharmaceuticals Plc (Jazz Pharmaceuticals) is a specialty biopharmaceutical company which identifies, develops, and commercializes medicines with focus on narcolepsy, cancer, pain, and psychiatry. Its marketed products include Xyrem (sodium oxybate) oral solution, Sunosi (solriamfetol), Erwinaze (asparaginase erwinia chrysanthemi), Defitelio (defibrotide sodium), Vyxeos (daunorubicin and cytarabine) liposome for injection, and others. The company also has various pipeline product candidates related to focus areas such as sleep, neurological disorders, hematology, and oncology including hematologic malignancies and solid tumors. The company sells...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Adamis Pharmaceuticals Corp

    Adamis Pharmaceuticals Corp (Adamis), formerly Cellegy Pharmaceuticals Inc, is a bio pharmaceutical company. The company's pipeline products includes SYMJEPI (epinephrine), ZIMHI(naloxone) and APC-400 (tempol). Its SYMJEPI Injection is used for the emergency treatment of allergic reactions such as caused by the stinging and biting insects, allergen immunotherapy, foods, drugs, diagnostic testing substances and other allergens, idiopathic and exercise-induced anaphylaxis. Adamis develops products in the form of injections, gels and capsules for the treatment of allergy, opioid overdose, respiratory and inflammatory...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Paratek Pharmaceuticals Inc

    Paratek Pharmaceuticals Inc (Paratek) is a e biopharmaceutical company that develops and commercializes therapies based on tetracycline chemistry. The company focuses on the development and commercialization of novel life-saving therapies for life-threatening diseases or other public health threats for civilian, government and military use. Nuzyra (Omadacycline), the company’s lead product candidate is an USFDA-approved broad-spectrum antibiotic for the treatment of adults with community-acquired bacterial pneumonia, acute bacterial skin and skin structure infections caused by susceptible bacteria. Its other product Seysara...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Regeneron Pharmaceuticals Inc

    Regeneron Pharmaceuticals Inc (Regeneron) is engaged in discovering, developing, manufacturing, and marketing medicines for the treatment of serious medical conditions. Its products are focused on helping patients suffering from cancer, allergic and inflammatory diseases, eye diseases, metabolic and cardiovascular diseases, infectious diseases, neuromuscular diseases, hematologic conditions, pain, and rare diseases. It develops products using its Trap and VelociSuite technology platforms, which include VelocImmune, VelociGene, VelociMouse, VelociMab, Veloci-Bi, VelociT, and other related technologies. The company operates manufacturing facilities in Rensselaer, New...

  • Innovation Ranking

    New
    $1,995 | March 2024
    Innovation Ranking
    New

    Innovation Ranking – Actinium Pharmaceuticals Inc

    Actinium Pharmaceuticals Inc (Actinium) develops antibody radiation conjugates (ARC), which combine the targeting ability of antibodies with the cell killing ability of radiation. The company's pipeline products include Iomab-B for hematopoietic stem cell transplantation, Iomab-ACT for the treatment of GeneTx and Cell therapy conditioning, Actimab-A(CD33) for the treatment of relapsed/refractory AML. The three variants of Actimab-A developed by company are- Actimab-A (CD33) and CLAG-M; Actimab-A (CD33) and Venetoclax and Actimab-A (CD33) and Venetoclax with HMA. The company also offers AWE...

Looking to stay on top of industry & market trends?

Sign up to receive regular alerts for our latest analysis and reports. No matter your industry focus, you can keep your finger on the pulse with our timely updates.